References
- Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol. 1992;128(5):702.
- Mirzoyev SA, Schrum AG, Davis MDP, et al. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990–2009. J Invest Dermatol. 2014;134(4):1141–1142.
- Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–1212.
- Kyriakis KP, Paltatzidou K, Kosma E, et al. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol. 2009;23(5):572–573.
- MacDonald Hull SP, Wood ML, Hutchinson PE, British Association of Dermatologists, et al. Guidelines for the management of alopecia areata. Br J Dermatol. 2003;149(4):692–699.
- Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55(3):438–441.
- Trueb RM, Dias M. Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol. 2018;54(1):68–87.
- Paus R, Bulfone-Paus S, Bertolini M. Hair follicle immune privilege revisited: the key to alopecia areata management. J Investig Dermatol Symp Proc. 2018;19(1):S12–S17.
- Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29(1):58–69.
- Rajabi F, Drake LA, Senna MM, et al. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179(5):1033–1048.
- Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993;66(6):541–554.
- Paus R, Bertolini M. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. J Investig Dermatol Symp Proc. 2013;16(1):S25–S27.
- Maciel LM, Rodrigues SS, Dibbern RS, et al. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid. 2001;11(1):31–35.
- Balducci-Silano PL, Layrisse Z, Dominguez E, et al. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population. Eur J Immunogenet. 1994;21(6):405–414.
- Milicic A, Lee D, Brown MA, et al. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol. 2002;29(9):1821–1826.
- Xiao F-L, Yang S, Yan K-l, et al. Association of HLA class I alleles with aloplecia areata in Chinese Hans. J Dermatol Sci. 2006;41(2):109–119.
- Xiao F-L, Ye D-Q, Yang S, et al. Association of HLA haplotype with alopecia areata in Chinese Hans. J Eur Acad Dermatol Venerol. 2006;20(10):1207–1213.
- Haida Y, Ikeda S, Takagi A, et al. Association analysis of the HLA-C gene in Japanese alopecia areata. Immunogenetics. 2013;65(7):553–557.
- Xiao F-L, Zhou F-S, Liu J-B, et al. Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch Dermatol Res. 2005;297(5):201–209.
- Megiorni F, Pizzuti A, Mora B, et al. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol. 2011;165(4):823–827.
- Olsen EA, Hordinsky MK, Price VH, *National Alopecia Areata Foundation, et al. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51(3):440–447.
- Blaumeiser B, van der Goot I, Fimmers R, et al. Familial aggregation of alopecia areata. J Am Acad Dermatol. 2006;54(4):627–632.
- Cole GW, Herzlinger D. Alopecia universalis in identical twins. Int J Dermatol. 1984;23(4):283.
- Rodriguez TA, Fernandes KE, Dresser KL, National Alopecia Areata Registry, et al. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010;62(3):525–527.
- Aliagaoglu C, Pirim I, Atasoy M, et al. Association between alopecia areata and HLA Class I and II in Turkey. J Dermatol. 2005;32(9):711–714.
- Akar A, Orkunoglu E, Sengül A, et al. HLA class II alleles in patients with alopecia areata. Eur J Dermatol. 2002;12(3):236–239.
- Kavak A, Baykal C, Ozarmağan G, et al. HLA in alopecia areata. Int J Dermatol. 2000;39(8):589–592.
- Starshinova A, Dovgalyuk I, Berkos A, et al. The effect of human leukocyte antigens-DRB1 alleles on development of different tuberculosis forms in children. Int J Mycobacteriol. 2018;7(2):117–121.
- Sastre-Garau X, Loste M-N, Vincent-Salomon A, et al. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer. 1996;69(3):159–164.
- Bhaskaran M, ArunKumar G. A meta-analysis of association of human leukocyte antigens A, B, C, DR and DQ with human papillomavirus 16 infection. Infect Genet Evol. 2019;68:194–202.
- Lopez C, Yepes-Pérez Y, Díaz-Arévalo D, et al. The in vitro antigenicity of Plasmodium vivax Rhoptry neck protein 2 (PvRON2) B- and T-epitopes selected by HLA-DRB1 binding profile. Front Cell Infect Microbiol. 2018;8:156.
- Behrangi E, Mansouri P, Agah S, et al. Association between Helicobacter pylori infection and alopecia areata: a study in Iranian population. Middle East J Dig Dis. 2017;9(2):107–110.
- Ito T, Tokura Y. Alopecia areata triggered or exacerbated by swine flu virus infection. J Dermatol. 2012;39(10):863–864.
- Skinner RB, Light WH, Bale GF Jr, et al. Alopecia areata and presence of cytomegalovirus DNA. JAMA. 1995;273(18):1419–1420.
- Rodriguez TA, Duvic M, National Alopecia Areata R, National Alopecia Areata Registry. Onset of alopecia areata after Epstein–Barr virus infectious mononucleosis. J Am Acad Dermatol. 2008;59(1):137–139.
- Lai YC, Yew YW. Severe autoimmune adverse events post Herpes Zoster Vaccine: a case-control study of adverse events in a national database. J Drugs Dermatol. 2015;14(7):681–684.
- Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations. JAMA. 1997;278(14):1176–1178.
- Geier DA, Geier MR. A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events. Clin Rheumatol. 2015;34(7):1225–1231.
- Saceda-Corralo D, Grimalt R, Fernández-Crehuet P, et al. Beard alopecia areata: a multicentre review of 55 patients. J Eur Acad Dermatol Venereol. 2017;31(1):187–192.
- Wolff H, Fischer TW, Blume-Peytavi U. The diagnosis and treatment of hair and scalp diseases. Dtsch Arztebl Int. 2016;113(21):377–386.
- Cervantes J, Fertig RM, Maddy A, et al. Alopecia areata of the beard: a review of the literature. Am J Clin Dermatol. 2017;18(6):789–796.
- Tan E, Tay Y-K, Goh C-L, et al. The pattern and profile of alopecia areata in Singapore–a study of 219 Asians. Int J Dermatol. 2002;41(11):748–753.
- Goh C, Finkel M, Christos PJ, et al. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venerol. 2006;20(9):1055–1060.
- Marques Da Costa C, Dupont E, Van der Cruys M, et al. Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Dermatology. 2006;213(1):12–14.
- Kavak A, Yeşildal N, Parlak AH, et al. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol. 2008;22(8):977–981.
- Zhang F-R, Liu H, Irwanto A, et al. HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med. 2013;369(17):1620–1628.
- Watanabe H, Watanabe Y, Tashiro Y, et al. A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome. J Dermatol Sci. 2017;88(3):320–329.
- Liu H, Wang Z, Bao F, Dapsone Hypersensitivity Syndrome Prevention Working Group, et al. Evaluation of prospective HLA-B*13:01 screening to prevent Dapsone hypersensitivity syndrome in patients with leprosy. JAMA Dermatol. 2019;155(6):666–672.
- Holoshitz J. The quest for better understanding of HLA-disease association: scenes from a road less travelled by. Discov Med. 2013;16(87):93–101.
- Yin L, Dai S, Clayton G, et al. Recognition of self and altered self by T cells in autoimmunity and allergy. Protein Cell. 2013;4(1):8–16.
- Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J. 1998;12(13):1255–1265.
- Whiting DA. Histopathologic features of alopecia areata: a new look. Arch Dermatol. 2003;139(12):1555–1559.
- McElwee KJ, Freyschmidt-Paul P, Hoffmann R, et al. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol. 2005;124(5):947–957.
- McElwee KJ, Spiers EM, Oliver RF. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol. 1996;135(2):211–217.